Jivdani Hospitals Profile
Key Indicators
- Authorised Capital ₹ 2.60 M
as on 07-07-2024
- Paid Up Capital ₹ 2.52 M
as on 07-07-2024
- Company Age 23 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.91 Cr
as on 07-07-2024
- Revenue -24.27%
(FY 2021)
- Profit -487.66%
(FY 2021)
- Ebitda -140.57%
(FY 2021)
- Net Worth -13.69%
(FY 2021)
- Total Assets -3.34%
(FY 2021)
About Jivdani Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.60 M and a paid-up capital of Rs 2.52 M.
The company has closed loans amounting to ₹3.91 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anuja Jadhav, Ramkumar Warrier, Santosh Kudalkar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24299MH2001PTC131801
- Company No.
131801
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Jivdani Hospitals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anuja Jadhav  | Director | 17-Nov-2018 | Current |
| Ramkumar Warrier | Director | 13-Apr-2001 | Current |
| Santosh Kudalkar | Director | 06-Jul-2002 | Current |
| Prasen Denkar | Director | 13-Apr-2001 | Current |
Financial Performance of Jivdani Hospitals.
Jivdani Hospitals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 24.27% decrease. The company also saw a substantial fall in profitability, with a 487.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jivdani Hospitals?
In 2021, Jivdani Hospitals had a promoter holding of 58.33% and a public holding of 41.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Nkgsb Co-Operative Bank Limited Creation Date: 29 Dec 2014 | ₹1.52 M | Satisfied |
Nkgsb Co-Operative Bank Limited Creation Date: 26 Sep 2014 | ₹1.00 M | Satisfied |
Nkgsb Co-Operative Bank Limited Creation Date: 15 Feb 2013 | ₹2.88 M | Satisfied |
How Many Employees Work at Jivdani Hospitals?
Unlock and access historical data on people associated with Jivdani Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jivdani Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jivdani Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
